NEW YORK – Insiders said late last week that Pfizer will name CME-KHBB/Minneapolis the agency for its new $10-million Reactine antihistamine business. Also, the company may give Tatham Euro RSCG an undisclosed product as a result of the pitch for the Reactine account. Neither agency would comment. Both agencies were finalists for the Reactine business.
Copyright Adweek L.P. (1993)
Get Adweek's Brand Marketing Daily Newsletter in your Inbox
Today's highs and lows of creativity